Key result
The trans-dimer encoded by HLA-DQA1*0501/DQB1*0302 demonstrated markedly impaired binding to a peptide antigen that interacts with DQ molecules encoded by both parental haplotypes.
The study demonstrates that trans-dimeric HLA-DQ molecules have distinct peptide binding properties compared to their cis-encoded counterparts, which may explain unique disease associations.
DQalpha and DQbeta trans heterodimeric HLA-DQ molecules form in individuals heterozygous for the DQ2 and DQ8 specificities. Unique functions and disease associations have been postulated for such trans-dimers, which may be different from cis-encoded DQ molecules encoded by the corresponding haplotypes. We analyzed the ability of the trans-dimer encoded by HLA-DQA1*0501/DQB1*0302 to bind a peptide antigen which interacts with DQ molecules encoded by both parental haplotypes. Markedly impaired binding was observed, consistent with both the use of different anchor residues and with changes in levels of DQ cis-dimer availability for peptide binding interactions.
No takes yet. Share an insight, caveat, or question.
Reichstetter et al. (1999) studied this question. HLA-DQA1*0501/DQB1*0302 trans-dimer vs. cis-encoded DQ molecules was evaluated on Binding to a peptide antigen (HSV VP16 peptide). The trans-dimer encoded by HLA-DQA1*0501/DQB1*0302 demonstrated markedly impaired binding to a peptide antigen that interacts with DQ molecules encoded by both parental haplotypes.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: